Published in Am Rev Respir Dis on December 01, 1989
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol (2003) 2.12
Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood (2012) 2.08
Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy (2004) 2.00
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax (2001) 1.85
Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol (2008) 1.76
Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax (1998) 1.72
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med (2009) 1.71
Platelets in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2015) 1.46
Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax (1998) 1.43
Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax (1993) 1.41
The cell biology of asthma. J Cell Biol (2014) 1.40
Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol (2003) 1.33
Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics (2004) 1.32
Investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med (2005) 1.32
Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22
Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med (1994) 1.22
Chronic inflammation and asthma. Mutat Res (2009) 1.22
Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am J Respir Crit Care Med (2010) 1.14
Cytokines. 3. Cytokines in asthma. Thorax (1993) 1.12
Airway remodelling in asthma: from benchside to clinical practice. Can Respir J (2010) 1.11
Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J (1994) 1.11
Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease. Histopathology (2012) 1.09
Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol (1994) 1.06
Airway epithelial repair: breathtakingly quick and multipotentially pathogenic. Thorax (1997) 1.03
The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin Exp Immunol (2004) 1.03
Interleukin-1beta mediates human airway epithelial cell migration via NF-kappaB. Am J Physiol Lung Cell Mol Physiol (2008) 0.98
Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. Thorax (1996) 0.97
Mediator and cytokine mechanisms in asthma. Thorax (1993) 0.97
Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction. Am J Pathol (2009) 0.97
PAF-induced bronchial hyperresponsiveness in the rabbit: contribution of platelets and airway smooth muscle. Br J Pharmacol (1990) 0.97
Rhinovirus-Induced Exacerbations of Asthma and COPD. Scientifica (Cairo) (2013) 0.97
In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa. Br J Pharmacol (1991) 0.96
Role of infection in the development and exacerbation of asthma. Expert Rev Respir Med (2010) 0.95
Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J Clin Invest (1993) 0.94
Reticular basement membrane in asthma and COPD: similar thickness, yet different composition. Int J Chron Obstruct Pulmon Dis (2009) 0.94
Pharmacological evaluation of a guinea-pig tracheal epithelium-derived inhibitory factor (EpDIF). Br J Pharmacol (1990) 0.94
Endogenous laminin is required for human airway smooth muscle cell maturation. Respir Res (2006) 0.93
Association of epithelial damage and signs of neutrophil mobilization in the airways during acute exacerbations of paediatric asthma. Clin Exp Immunol (2006) 0.93
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation. Respir Res (2006) 0.92
The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by repeated elicitation. Am J Pathol (2007) 0.92
Measurement of airway hyperresponsiveness: new considerations. Thorax (1998) 0.91
Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis. Mediators Inflamm (2012) 0.91
Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow. Thorax (1991) 0.90
Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol (2007) 0.90
Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time. Thorax (1998) 0.89
Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc Natl Acad Sci U S A (1998) 0.89
Regional differences in the pattern of airway remodeling following chronic allergen exposure in mice. Respir Res (2006) 0.89
Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study. Thorax (1996) 0.88
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ (1995) 0.87
Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir Res (2005) 0.87
The safety and quality of endobronchial biopsy in children under five years old. Thorax (2003) 0.86
Maternal asthma and microRNA regulation of soluble HLA-G in the airway. J Allergy Clin Immunol (2013) 0.86
Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts. Inflammation (2003) 0.86
Insulin receptor substrate-1/2 mediates IL-4-induced migration of human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2009) 0.86
Co-expression of CD25 and CD3 in atopic allergy and asthma. Immunology (1992) 0.85
Heat shock protein-27 protects human bronchial epithelial cells against oxidative stress-mediated apoptosis: possible implication in asthma. Cell Stress Chaperones (2002) 0.85
Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study. NPJ Prim Care Respir Med (2014) 0.85
Apoptosis and the airway epithelium. J Allergy (Cairo) (2011) 0.85
Etiology and pathogenesis of airway disease in children and adults from rural communities. Environ Health Perspect (1999) 0.84
Immunological Interactive Effects between Pollen Grains and Their Cytoplasmic Granules on Brown Norway Rats. World Allergy Organ J (2009) 0.84
Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging. Br J Pharmacol (2003) 0.84
Contractile properties of synthetic cationic polypeptides in guinea-pig isolated trachea. Br J Pharmacol (1994) 0.83
Arhgef1 is required by T cells for the development of airway hyperreactivity and inflammation. Am J Respir Crit Care Med (2007) 0.81
Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol (2014) 0.81
Evidence that epithelium-dependent relaxation of vascular smooth muscle detected by co-axial bioassays is not attributable to hypoxia. Br J Pharmacol (1992) 0.81
The release of a non-prostanoid inhibitory factor from rabbit bronchus detected by co-axial bioassay. Br J Pharmacol (1991) 0.81
Chemokines and their role in airway hyper-reactivity. Respir Res (2000) 0.81
Glucocorticoids modulate TGF-beta production. Inflammation (2002) 0.81
Ultrastructural changes of airway in murine models of allergy and diet-induced metabolic syndrome. ISRN Allergy (2013) 0.81
Asthma and COPD - The C/EBP Connection. Open Respir Med J (2012) 0.81
Gene expression profiling in lungs of chronic asthmatic mice treated with galectin-3: downregulation of inflammatory and regulatory genes. Mediators Inflamm (2011) 0.80
Synergistic action of endothelin (ET)-1 on the activation of bronchial fibroblast isolated from normal and asthmatic subjects. Int J Exp Pathol (2000) 0.80
Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa. Br J Pharmacol (1993) 0.80
Steroid response in refractory asthmatics. Korean J Intern Med (2012) 0.80
Variability of inflammatory cell counts on bronchial biopsies of normal subjects. Lung (2003) 0.79
Bronchial hyperresponsiveness in lung transplant recipients: lack of correlation with airway inflammation. Thorax (1997) 0.79
The contribution of L-selectin to airway hyperresponsiveness in chronic allergic airways disease. J Asthma Allergy (2010) 0.79
Responsiveness of human isolated bronchial segments and its relationship to epithelial loss. Br J Clin Pharmacol (1993) 0.79
Relationship among pulmonary function, bronchial hyperresponsiveness, and atopy in children with clinically stable asthma. Lung (2006) 0.79
Effect of theophylline and specific phosphodiesterase IV inhibition on proliferation and apoptosis of progenitor cells in bronchial asthma. Br J Pharmacol (2003) 0.79
Effects of topical budesonide on epithelial restitution in vivo in guinea pig trachea. Thorax (1995) 0.79
Asthmatics without rhinitis have more fixed airway obstruction than those with concurrent rhinitis. Allergy Asthma Immunol Res (2010) 0.79
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection. BMC Immunol (2014) 0.78
Effects of hyperosmolarity on human isolated central airways. Br J Pharmacol (1991) 0.78
The extracellular matrix - the under-recognized element in lung disease? J Pathol (2016) 0.78
Key role of water-insoluble allergens of pollen cytoplasmic granules in biased allergic response in a rat model. World Allergy Organ J (2011) 0.77
Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury. Br J Pharmacol (1996) 0.77
Ultrastructural Comparison of the Nasal Epithelia of Healthy and Naturally Affected Rabbits with Pasteurella multocida A. Vet Med Int (2013) 0.77
The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. Br J Clin Pharmacol (1993) 0.77
Time sequence of airway remodeling in a mouse model of chronic asthma: the relation with airway hyperresponsiveness. J Korean Med Sci (2007) 0.77
Allergic Rhinitis in Preschool Children and the Clinical Utility of FeNO. Allergy Asthma Immunol Res (2017) 0.77
Fluticasone Induces Epithelial Injury and Alters Barrier Function in Normal Subjects. J Steroids Horm Sci (2014) 0.76
Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy? Mediators Inflamm (1996) 0.76
Significance of Mouse Models in Dissecting the Mechanism of Human Eosinophilic Gastrointestinal Diseases (EGID). J Gastroenterol Hepatol Res (2015) 0.76
Inflammatory cell distribution in guinea pig airways and its relationship to airway reactivity. Mediators Inflamm (2001) 0.76
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
Intravenous corticosteroids in treatment of acute bronchial asthma. Lancet (1970) 4.37
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med (1972) 3.93
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84
Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol (1971) 3.51
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
Non-eosinophilic corticosteroid unresponsive asthma. Lancet (1999) 3.25
Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet (1989) 3.15
Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol (1970) 3.09
The use of corticosteroids in the treatment of acute asthma. Q J Med (1975) 2.95
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol (1991) 2.88
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J (2007) 2.78
An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med (1971) 2.65
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet (2002) 2.38
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ (1991) 2.32
T cells and eosinophils in the pathogenesis of asthma. Immunol Today (1992) 2.30
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol (1997) 2.28
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax (1980) 2.28
CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis (1990) 2.18
Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy (1985) 2.15
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. Clin Exp Immunol (1970) 2.13
Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol (1993) 2.11
Chemical inactivation of HIV on surfaces. BMJ (1989) 2.08
"Acute" asthma in adults. Thorax (1979) 2.07
Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet (1992) 2.06
Leucoattractants enhance complement receptors on human phagocytic cells. Clin Exp Immunol (1979) 2.04
Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med (2000) 2.03
Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation. Thorax (1986) 2.02
The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol (1988) 2.00
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology (1990) 1.85
Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol (1982) 1.84
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis (1991) 1.84
Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med (1995) 1.83
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax (1980) 1.82
Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J (2000) 1.81
T lymphocyte activation in acute severe asthma. Lancet (1988) 1.81
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest (1982) 1.77
Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax (2003) 1.75
Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) (1981) 1.75
The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen. Br J Haematol (1974) 1.70
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Eosinophils 1992. Immunol Today (1992) 1.69
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis (1992) 1.68
Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol (1991) 1.67
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol (1993) 1.67
The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today (1999) 1.67
Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol (2001) 1.67
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest (1993) 1.66
Respiratory depression caused by nitrazepam in patients with respiratory failure. Lancet (1971) 1.64
Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med (1996) 1.64
Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med (1991) 1.64
Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol (1989) 1.63
Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. J Immunol (1977) 1.63
New insights into the role of the mast cell in asthma. Clin Exp Allergy (2003) 1.61
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol (1992) 1.59
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood (1992) 1.59
Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol (1983) 1.56
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils. J Immunol (1979) 1.53
Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy (1999) 1.53
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy (2005) 1.52
Interaction between isoprenaline and aminophylline in asthma. Thorax (1977) 1.52
Expression of CCR8 is increased in asthma. Clin Exp Allergy (2010) 1.51
Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature (1985) 1.51
Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med (1982) 1.51
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.50
Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med (1999) 1.48
Bronchoscopy and infection control. Lancet (1989) 1.48
Infection control revisited: dilemma facing today's bronchoscopists. BMJ (1988) 1.46
Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. Lancet (1977) 1.45
The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature (1977) 1.43
CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis (1993) 1.43
Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol (1995) 1.42